What This Guide Covers and Who It Is For
This guide is for anyone taking medications that may affect jawbone health, including bisphosphonates and denosumab. It covers causes, warning signs, prevention, and treatment options for MRONJ.
MRONJ stands for medication-related osteonecrosis of the jaw. "Osteonecrosis" means bone death. In MRONJ, a section of jawbone loses its blood supply and dies. The dead bone then becomes exposed through the gum tissue and does not heal. [5]
The American Association of Oral and Maxillofacial Surgeons (AAOMS) defines MRONJ by three criteria: current or previous treatment with antiresorptive or antiangiogenic drugs, exposed bone or bone that can be probed through an opening in the mouth persisting for more than eight weeks, and no history of radiation therapy to the jaw area. [5]
Millions of people take bisphosphonates for osteoporosis or cancer-related bone conditions. Most of them will never develop MRONJ. However, understanding the risk factors and prevention steps is critical for anyone on these medications. This guide will help you have informed conversations with your doctors, dentist, and oral surgeon.
Causes, Risk Factors, and Symptoms of MRONJ
MRONJ is caused by medications that slow or stop the natural turnover of bone cells, leaving the jaw vulnerable to injury that cannot heal properly.
Medications Linked to MRONJ
Several categories of drugs are associated with MRONJ. The most common are antiresorptive drugs, which slow bone breakdown. These include bisphosphonates (such as alendronate, risedronate, zoledronic acid, and pamidronate) and denosumab (Prolia, Xgeva). [5]
Antiangiogenic drugs are another category. These medications block the growth of new blood vessels and are used in cancer treatment. Examples include bevacizumab (Avastin) and sunitinib (Sutent). The AAOMS 2022 position paper recognizes both antiresorptive and antiangiogenic medications as potential causes. [5]
Bisphosphonates work by binding to bone and inhibiting cells called osteoclasts, which are responsible for breaking down old bone. This binding is long-lasting. Even after a patient stops taking bisphosphonates, the drug remains in the bone for years. [2] Denosumab works differently. It blocks a protein called RANKL that osteoclasts need to function. Its effects wear off more quickly after stopping the drug, but MRONJ risk still exists during treatment. [5]
Who Is Most at Risk
The risk of developing MRONJ varies widely depending on the medication, the dose, and how it is given. Cancer patients receiving high-dose intravenous (IV) bisphosphonates like zoledronic acid face the highest risk, estimated at roughly 1% to 15%. [5] Osteoporosis patients taking oral bisphosphonates at lower doses have a much lower risk, estimated at roughly 0.01% to 0.1%. [5]
Several additional factors increase the likelihood of MRONJ. Invasive dental procedures, especially tooth extractions, are the most common trigger. A systematic review and meta-analysis found that tooth extraction is a significant prognostic factor associated with poorer outcomes. [3] Dental implant placement has also been identified as a potential trigger in at-risk patients. [4]
Other risk factors include poor oral hygiene, ill-fitting dentures that create sore spots on the gums, longer duration of drug therapy, concurrent use of corticosteroids, diabetes, smoking, and older age. [5] [8] Patients taking both antiresorptive and antiangiogenic drugs face compounded risk.
Symptoms and Stages of MRONJ
Early MRONJ may not cause pain. Some patients first notice exposed bone in their mouth, often after a tooth extraction or other dental procedure. The exposed bone typically feels rough to the tongue. [8]
As the condition progresses, symptoms may include pain or numbness in the jaw, swelling of the gums or jaw, loosening of teeth near the affected area, pus draining from the gum tissue, and a foul taste in the mouth. In advanced cases, the dead bone can lead to a fracture of the jaw or an opening (fistula) between the mouth and the skin of the face. [5]
The AAOMS uses a staging system to classify MRONJ severity. Stage 0 involves no visible exposed bone but includes non-specific symptoms like jaw pain or bone changes on imaging. Stage 1 means exposed bone is present but there is no infection. Stage 2 includes exposed bone with infection, pain, and swelling. Stage 3 involves exposed bone with infection that extends beyond the jawbone area, potentially causing a jaw fracture or fistula. [5]
What You Need to Know Before Starting At-Risk Medications
Prevention before starting medication is the single most effective step to reduce your risk of developing MRONJ. [5]
The Pre-Medication Dental Evaluation
If your physician has recommended bisphosphonates, denosumab, or antiangiogenic therapy, a dental evaluation should happen before you begin. The AAOMS and multiple international guidelines recommend this step. [5] [8] The goal is to identify and treat any dental problems that might later require invasive procedures while you are on the medication.
During this evaluation, your dentist or oral surgeon will check for cavities, gum disease, teeth that may need extraction, and any other conditions likely to need surgery in the near future. Completing this dental work before starting medication allows your jawbone to heal normally. [5]
A study found that many patients taking bisphosphonates were unaware of the associated jaw risks. [6] This highlights the importance of communication between your prescribing physician and your dental team. If your doctor prescribes one of these medications, ask about MRONJ and request a referral for a dental checkup before you start.
Ongoing Dental Care While on Medication
Once you are taking an at-risk medication, good oral hygiene becomes even more important. Brush twice daily, floss regularly, and see your dentist for routine checkups. The goal is to prevent dental problems that would require invasive treatment. [8]
If you do need dental treatment, inform every dental provider about your medication. Share the name of the drug, the dose, how long you have been taking it, and the condition it treats. This information helps your dentist and oral surgeon plan the safest approach. [5] [6]
For patients on oral bisphosphonates for osteoporosis, routine dental procedures like cleanings, fillings, and root canals are typically considered safe. Extractions and implant surgery carry more risk and require careful planning. [5] Whether to pause the medication before a procedure (a "drug holiday") is a decision made jointly by your prescribing physician and your dental specialist. Current evidence on the benefit of drug holidays is limited, and the decision depends on your individual medical situation. [2] [5]
Dental Implants in Patients on Antiresorptive Drugs
Dental implant placement in patients taking bisphosphonates or denosumab requires careful evaluation. A scoping review found that dental implants can trigger MRONJ, though reported cases remain relatively uncommon. [4] The risk appears higher in patients receiving IV bisphosphonates for cancer compared to those on oral bisphosphonates for osteoporosis.
If you are considering dental implants and currently take antiresorptive medication, your oral surgeon will assess your individual risk level. Factors include the type and duration of your drug therapy, your overall health, and the location of the planned implant. The decision requires collaboration between your oral surgeon and prescribing physician. [4] [5]
What to Expect: Diagnosis and Treatment of MRONJ
Diagnosis typically involves a clinical examination of the mouth combined with imaging studies such as a CT scan to assess the extent of bone involvement.
How MRONJ Is Diagnosed
Your oral surgeon will examine your mouth looking for exposed bone, signs of infection, and areas of gum breakdown. They will ask about your medication history, when symptoms started, and whether you had a recent dental procedure. [5]
Imaging plays an important role. A panoramic X-ray may show areas of bone loss. A cone-beam CT (CBCT) or medical CT scan provides a detailed three-dimensional view of the jawbone and can reveal the full extent of dead bone that may not be visible on a standard X-ray. [8] In some cases, a biopsy (small tissue sample) may be taken to rule out other conditions, such as bone cancer.
Treatment Options by Stage
Treatment depends on the stage of the disease and the patient's overall health. The AAOMS provides treatment guidelines for each stage. [5]
For Stage 0 (no exposed bone, non-specific symptoms), treatment is typically conservative. This may include pain medication and antibiotics if infection is suspected. For Stage 1 (exposed bone without infection), treatment focuses on antimicrobial mouth rinses, such as chlorhexidine, and close monitoring. [5]
Stage 2 (exposed bone with infection) typically requires antibiotics in addition to antimicrobial rinses. Pain management is also part of care. In some cases, the oral surgeon may carefully remove loose pieces of dead bone that are irritating the soft tissue. [5] For Stage 3 (advanced disease), surgical removal of the dead bone (debridement or resection) is often necessary. This may involve removing a section of the jawbone and, in some cases, reconstructive surgery. [5]
A systematic review and meta-analysis examining prognostic indicators found that treatment outcomes vary by stage, with earlier stages generally responding better to conservative management. The review also found that the type of medication and the specific location in the jaw can influence prognosis. [3]
Additional and Emerging Therapies
Beyond standard care, some additional treatments have been studied. Pentoxifylline combined with tocopherol (a form of vitamin E) has been evaluated as an adjunct therapy for MRONJ. A systematic review found early evidence suggesting potential benefit, though the authors noted that the quality of available studies was limited and more research is needed. [7]
Ozone therapy has also been explored as a treatment option. A scoping review examining available studies found that ozone therapy showed some promise as an adjunctive treatment, but the evidence remains preliminary. The review called for higher-quality clinical trials before firm conclusions can be drawn. [1]
Other approaches under investigation include platelet-rich plasma (PRP) therapy and low-level laser therapy. These treatments aim to promote healing in the affected area. Your oral surgeon can discuss whether any of these options may be appropriate for your specific situation.
Cost Factors for MRONJ Treatment
Treatment costs for MRONJ vary widely depending on the severity of the condition and the type of treatment required.
Conservative management involving antibiotics and antimicrobial rinses is generally the least expensive approach. Costs typically include office visits, prescriptions, and periodic imaging. Surgical treatment for advanced MRONJ can be significantly more costly, particularly if it involves hospital-based surgery, general anesthesia, or jaw reconstruction.
Medical insurance may cover portions of MRONJ treatment because it is a side effect of a prescribed medication. Dental insurance may also apply depending on the specific procedures. Coverage varies widely between plans. Contact both your medical and dental insurance providers to understand what is covered in your case. Many oral surgeons' offices have staff who can help verify your benefits.
Costs vary by location, provider, and case complexity. Ask your oral surgeon's office for an estimate based on your diagnosis and treatment plan before beginning care.
When to See an Oral Surgeon
You should see an oral surgeon if you notice exposed bone in your mouth, unexplained jaw pain, or gum swelling while taking antiresorptive or antiangiogenic drugs.
Specific situations that call for a specialist evaluation include: any visible bone showing through the gums that does not heal within eight weeks, persistent jaw pain or numbness that your general dentist cannot explain, drainage of pus from the gum tissue, loosening of teeth without an obvious dental cause, and a jaw fracture without significant trauma. [5]
You should also see an oral surgeon before starting bisphosphonate or denosumab therapy if your general dentist identifies teeth that may need extraction or other surgical treatment. An oral surgeon can coordinate the timing of dental procedures with your medication schedule to reduce your MRONJ risk. [5]
If you have been taking bisphosphonates or denosumab and need a tooth extraction, dental implant, or other jaw surgery, an oral surgeon experienced with MRONJ is the appropriate specialist. They can assess your individual risk and plan the procedure to minimize complications. [4] [5]
Find an Oral Surgeon Near You
If you take bisphosphonates, denosumab, or antiangiogenic medications and have concerns about your jaw health, finding a qualified oral surgeon is an important step. Use the My Specialty Dentist directory to search for an oral and maxillofacial surgeon in your area who can evaluate your risk, plan preventive care, or treat existing MRONJ.
Search Oral Surgeons in Your Area